Recruiting NCT06529614
An In-situ Detection for MicroRNA
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: In-situ detection for Micro-RNA.
- Who it may be relevant to
- Registry conditions: Breast Cancer. Basic parameters: 18 years — 75 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A New Detection Method for MicroRNA in Patients With Breast Cancer
Overview
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
Interventions
- Other In-situ detection for Micro-RNA
a new in-situ detection methods for Micro-RNA
Primary outcome measures
- Sensitivity and specificity of test [Time frame: 8 months]
Eligibility criteria
Inclusion Criteria: Healthy without serious diseases
\-
Exclusion criteria
- situations that may affect the results
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
China · 1 center
- Tongji Hospital — Wuhan
Identifiers
NCT: NCT06529614 · 20240771